Stingeze
NDC Package 68093-7151-1
Package Information
Stingeze is clean areaApply a small amount to the bite area while massaging with sponge tip applicator. If itching persists, apply again in 10-15 minutesFor ticks and bees, remove tick or stinger before treatmentAdults and children 2 years and over: Apply to affected area 1 to 3 times dailyChildren under 2 years: Consult a doctor. Marketed by Wisconsin Pharmacal Company, this product is identified by NDC 68093-7151 and is authorized under FDA application part348.
Identification & Billing
- RxCUI: 1485210 - benzocaine 10 % / camphor 3 % / phenol 1.35 % Topical Solution
- RxCUI: 1485210 - benzocaine 100 MG/ML / camphor 30 MG/ML / phenol 13.5 MG/ML Topical Solution
- RxCUI: 1485215 - StingEze MAX 10 % / 3 % / 1.35 % Topical Solution
- RxCUI: 1485215 - benzocaine 100 MG/ML / camphor 30 MG/ML / phenol 13.5 MG/ML Topical Solution [Stingeze Max]
- RxCUI: 1485215 - Stingeze Max (benzocaine 10 % / camphor 3 % / phenol 1.35 % ) Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68093 - Wisconsin Pharmacal Company
- 68093-7151 - Stingeze
- 68093-7151-1 - 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 14.8 g in 1 BOTTLE, WITH APPLICATOR
- 68093-7151 - Stingeze
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68093-7151-1 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 14.8 g in 1 bottle, with applicator of Stingeze Max Insect Bite Relief, labeled by Wisconsin Pharmacal Company. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wisconsin Pharmacal Company on February 01, 2009. The current certification is valid through December 31, 2019.
How is this Wisconsin Pharmacal Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68093715101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.